TAN vs. CURE

Last updated Jun 3, 2026

TAN (Invesco Solar ETF) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both exchange-traded funds - TAN is a Alternative Energy Equities fund tracking the MAC Global Solar Energy Index, while CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, TAN returned 13.81%/yr vs 11.41%/yr for CURE. At a 0.38 correlation, their price movements are largely independent. TAN charges 0.69%/yr vs 1.08%/yr for CURE.

Performance

TAN vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Solar ETF (TAN) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TAN achieves a 47.13% return, which is significantly higher than CURE's -20.11% return. Over the past 10 years, TAN has outperformed CURE with an annualized return of 13.81%, while CURE has yielded a comparatively lower 11.41% annualized return.

TAN

• 1D: 1.60%
• 1M: 21.93%
• YTD: 47.13%
• 6M: 51.73%
• 1Y: 127.12%
• 3Y*: 0.29%
• 5Y*: -0.77%
• 10Y*: 13.81%

CURE

• 1D: -2.92%
• 1M: 1.15%
• YTD: -20.11%
• 6M: -19.30%
• 1Y: 19.67%
• 3Y*: -0.86%
• 5Y*: -0.04%
• 10Y*: 11.41%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TAN vs. CURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TAN Invesco Solar ETF	47.13%	48.31%	-37.61%	-26.79%	-5.24%	-25.10%	233.96%	66.53%	-25.67%	54.38%
CURE Direxion Daily Healthcare Bull 3x Shares	-20.11%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%

Correlation

The correlation between TAN and CURE is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.29
Correlation (10Y) Calculated over the trailing 10-year period	0.34
Correlation (All Time) Calculated using the full available price history since Jun 16, 2011	0.38

Over the past year, the correlation between TAN and CURE has dropped to 0.18 - well below their long-term average of 0.38, suggesting their price drivers have been diverging.

TAN vs. CURE - Sectors Allocation Comparison

Sectors	TAN	CURE
Energy	57.3%	-
Utilities	22.1%	-
Technology	9.7%	-
Financial Services	3.6%	-
Industrials	3.3%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Healthcare	-	100.0%
Real Estate	-	-

Return for Risk

TAN vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TAN

TAN Risk / Return Rank: 89
TAN Sharpe Ratio Rank: 93
TAN Sortino Ratio Rank: 87
TAN Omega Ratio Rank: 80
TAN Calmar Ratio Rank: 96
TAN Martin Ratio Rank: 91

CURE

CURE Risk / Return Rank: 17
CURE Sharpe Ratio Rank: 16
CURE Sortino Ratio Rank: 19
CURE Omega Ratio Rank: 18
CURE Calmar Ratio Rank: 16
CURE Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TAN vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Solar ETF (TAN) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TAN	CURE	Difference
Sharpe ratio Return per unit of total volatility	3.44	0.46	+2.98
Sortino ratio Return per unit of downside risk	3.94	0.98	+2.96
Omega ratio Gain probability vs. loss probability	1.48	1.11	+0.37
Calmar ratio Return relative to maximum drawdown	9.06	0.64	+8.42
Martin ratio Return relative to average drawdown	22.01	1.49	+20.52
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TAN vs. CURE - Sharpe Ratio Comparison

The current TAN Sharpe Ratio is 3.44, which is higher than the CURE Sharpe Ratio of 0.46. The chart below compares the historical Sharpe Ratios of TAN and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TAN	CURE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.44	0.46	+2.98
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.02	-0.00	-0.02
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.37	0.23	+0.13
Sharpe Ratio (All Time) Calculated using the full available price history	-0.12	0.46	-0.57

Drawdowns

TAN vs. CURE - Drawdown Comparison

The maximum TAN drawdown since its inception was -95.29%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for TAN and CURE.

Drawdown Indicators

	TAN	CURE	Difference
Max Drawdown Largest peak-to-trough decline	-95.29%	-69.19%	-26.10%
Max Drawdown (1Y) Largest decline over 1 year	-13.62%	-31.10%	+17.48%
Max Drawdown (3Y) Largest decline over 3 years	-64.40%	-51.93%	-12.47%
Max Drawdown (5Y) Largest decline over 5 years	-73.95%	-52.23%	-21.72%
Max Drawdown (10Y) Largest decline over 10 years	-78.53%	-69.19%	-9.34%
Current Drawdown Current decline from peak	-66.81%	-36.59%	-30.22%
Average Drawdown Average peak-to-trough decline	-78.51%	-18.14%	-60.37%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.61%	13.34%	-7.73%

Volatility

TAN vs. CURE - Volatility Comparison

Invesco Solar ETF (TAN) and Direxion Daily Healthcare Bull 3x Shares (CURE) have volatilities of 11.81% and 11.87%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TAN	CURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.81%	11.87%	-0.06%
Volatility (6M) Calculated over the trailing 6-month period	25.30%	30.02%	-4.72%
Volatility (1Y) Calculated over the trailing 1-year period	37.21%	43.14%	-5.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	39.74%	43.68%	-3.94%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.98%	49.51%	-11.53%

TAN vs. CURE - Expense Ratio Comparison

TAN has a 0.69% expense ratio, which is lower than CURE's 1.08% expense ratio.

Dividends

TAN vs. CURE - Dividend Comparison

TAN has not paid dividends to shareholders, while CURE's dividend yield for the trailing twelve months is around 1.34%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CURE Direxion Daily Healthcare Bull 3x Shares	1.34%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%	0.00%	0.00%
TAN Invesco Solar ETF	0.00%	0.00%	0.50%	0.09%	0.00%	0.00%	0.09%	0.30%	0.69%	1.77%	5.04%	1.60%

Frequently Asked Questions

Can I hold both TAN and CURE in my portfolio?

TAN and CURE have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TAN or CURE?

CURE has higher volatility (11.87%) compared to TAN (11.81%). In terms of maximum drawdown, TAN dropped -95.29% vs CURE's -69.19%.

Which ETF is better, TAN or CURE?

On 10-year performance, TAN leads with 13.81% vs 11.41% for CURE. On fees, TAN is cheaper at 0.69% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, TAN or CURE?

Over the 10-year period, TAN has performed better with a 13.81% return vs 11.41%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, TAN or CURE?

TAN is cheaper with a 0.69% expense ratio, compared with 1.08% for CURE.

Which ETF pays a higher dividend yield, TAN or CURE?

CURE has the higher dividend yield at 1.34%, compared with 0.00% for TAN.

What is the main difference between TAN and CURE?

TAN is categorized as Alternative Energy Equities, while CURE is Leveraged Equities. TAN tracks MAC Global Solar Energy Index, while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: Invesco and Direxion. Their fees differ too: 0.69% for TAN and 1.08% for CURE.

Which has better risk-adjusted returns?

TAN currently has the higher Sharpe Ratio (3.44 vs 0.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.